Lobbying

America's Blood Centers's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $60K. Its first report covers Q4 2022; the issues it reports most are Disaster Planning/Emergencies and Health Issues.

America's Blood Centers

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$60K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

America's Blood Centers lobbying by quarter
America's Blood Centers lobbying by quarter
QuarterAmountReports
Q4 2022$20K1
Q1 2023$20K1
Q2 2023$20K1
Q3 2023$20K1
Q4 2023$20K1
Q1 2024$20K1
Q2 2024$20K1
Q3 2024$20K1
Q4 2024$20K1
Q1 2025$20K1
Q2 2025$20K1
Q3 2025$20K1
Q4 2025$20K1
Q1 2026$20K1
Q2 2026$20K1
Q3 2026$00

By issue

  • Disaster planning and emergencies$98.3K · 15 reports
  • Health issues$98.3K · 15 reports
  • Medical research and clinical labs$98.3K · 15 reports
  • Budget and appropriations$5,000 · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Disease Control & Prevention (CDC)15 reports
  • Centers For Medicare and Medicaid Services (CMS)15 reports
  • Food & Drug Administration (FDA)15 reports
  • Health & Human Services, Dept of (HHS)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • White House Office15 reports
  • Defense, Dept of (DOD)1 reports
  • Homeland Security, Dept of (DHS)1 reports

Firms it paid

Firm
In-houseAmerica's Blood Centers$300K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/02for Q2In-house$20K
04/20for Q1In-house$20K
02/03for Q4 2025In-house$20K
25/10/20for Q3 2025In-house$20K
25/08/05for Q2 2025In-house$20K
25/04/24for Q1 2025In-house$20K
25/02/04for Q4 2024In-house$20K
24/11/07for Q3 2024In-house$20K
24/08/06for Q2 2024In-house$20K
24/05/02for Q1 2024In-house$20K
24/01/18for Q4 2023In-house$20K
23/11/17for Q3 2023In-house$20K
23/07/06for Q2 2023In-house$20K
23/05/04for Q1 2023In-house$20K
23/01/30for Q4 2022In-house$20K